Table 3.
Unadjusted Odds Ratios | Adjusted Odds Ratios | |||||
---|---|---|---|---|---|---|
OR | 95 % CI | P-value | aOR | 95 % CI | P-value | |
Timing of ART Initiation | ||||||
In Pregnancy | 1.72 | 1.37, 2.17 | < 0.001 | 1.62 | 1.28, 2.05 | < 0.001 |
In Breastfeeding | --- | |||||
Age | ||||||
< 30 years | 1.33 | 1.07, 1.65 | 0.01 | 1.27 | 1.02, 1.57 | 0.03 |
> 30 years | --- | |||||
Health Facility Size | ||||||
Small (< 100) | --- | --- | --- | |||
Medium (100–500) | 1.00 | 0.52, 1.92 | 0.99 | |||
Large (> 500) | 1.19 | 0.59, 2.41 | 0.62 | |||
WHO Clinical Stage at Initiation | ||||||
Stage 1 | --- | --- | --- | --- | --- | --- |
Stage 2 | 0.58 | 0.37, 0.92 | 0.02 | 0.62 | 0.39, 0.98 | 0.04 |
Stage 3–4 Not documented |
0.26 1.15 |
0.13, 0.52 0.91, 1.47 |
< 0.001 0.24 |
0.30 1.18 |
0.15, 0.60 0.93, 1.50 |
< 0.001 0.18 |
Adjusted for timing, age and clinical stage
If a woman was not observed for at least 30 days, they are removed from the analysis